Biotechnology equipment spells big bucks for the industry’s top CEOs. [© ALYUSHIN - Fotolia.com]
Below is a list of CEOs of publicly traded companies focused principally on life sciences instrumentation and consumables, ranked by their 2011 total compensation as included in public filings, with comparison to 2010 total compensation. For U.S. companies, the source for compensation figures are the summary compensation tables contained within the DEF 14A proxy statements filed by public companies with the U.S. Securities and Exchange Commission (SEC). For companies headquartered outside the U.S., compensation information is included within Form 20-Fs also filed with SEC.
#15. Fluidigm
Gajus V. Worthington, President and CEO
2011 Compensation: $1,108,469
2010 Compensation: $379,555
% Change: 192.0%
#14. Qiagen
Peer M. Schatz, Managing Director, CEO
2011 Compensation: $1,845,000
2010 Compensation: $1,722,000
% Change: 7.1%
#13. Waters
Douglas A. Berthiaume, Chairman, President, and CEO
2011 Compensation: $2,646,730
2010 Compensation: $2,442,165
% Change: 8.4%
#12. Affymetrix
Frank Witney, Ph.D., President and CEO
2011 Compensation: $2,739,835
2010 Compensation: N/A (Appointed July 2011)
% Change: N/A
#11. Sequenom
Harry F. Hixson Jr., CEO
2011 Compensation: $3,154,159
2010 Compensation: $1,052,580
% Change: 199.7%
#10. Bio-Rad Laboratories
Norman Schwartz, President and CEO
2011 Compensation: $3,844,998
2010 Compensation: $3,949,151
% Change: -2.6%
#9. Sigma-Aldrich
Rakesh Sachdev, President and CEO
2011 Compensation: $3,915,529
2010 Compensation: $2,276,031
% Change: 72.0%
#8. Cepheid
John L. Bishop, CEO and Director
2011 Compensation: $4,576,225
2010 Compensation: $3,029,842
% Change: 51.0%